Figure 2From: A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial Study design. ADV, adenovirus; CMV, cytomegalovirus; HSV, adenovirus; Tvis, virus-specific T cells.Back to article page